1. Home
  2. OMH vs VRAX Comparison

OMH vs VRAX Comparison

Compare OMH & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMH
  • VRAX
  • Stock Information
  • Founded
  • OMH 2015
  • VRAX 2013
  • Country
  • OMH Singapore
  • VRAX United Kingdom
  • Employees
  • OMH N/A
  • VRAX N/A
  • Industry
  • OMH Real Estate
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • OMH Finance
  • VRAX Health Care
  • Exchange
  • OMH Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • OMH 8.0M
  • VRAX 7.3M
  • IPO Year
  • OMH 2023
  • VRAX 2022
  • Fundamental
  • Price
  • OMH $0.37
  • VRAX $1.88
  • Analyst Decision
  • OMH Strong Buy
  • VRAX
  • Analyst Count
  • OMH 1
  • VRAX 0
  • Target Price
  • OMH $1.50
  • VRAX N/A
  • AVG Volume (30 Days)
  • OMH 85.6K
  • VRAX 300.5K
  • Earning Date
  • OMH 09-25-2024
  • VRAX 02-05-2025
  • Dividend Yield
  • OMH N/A
  • VRAX N/A
  • EPS Growth
  • OMH N/A
  • VRAX N/A
  • EPS
  • OMH N/A
  • VRAX N/A
  • Revenue
  • OMH $5,390,607.00
  • VRAX $84,872.00
  • Revenue This Year
  • OMH $101.90
  • VRAX $5,169.18
  • Revenue Next Year
  • OMH $38.34
  • VRAX $66.97
  • P/E Ratio
  • OMH N/A
  • VRAX N/A
  • Revenue Growth
  • OMH 25.77
  • VRAX 7.03
  • 52 Week Low
  • OMH $0.32
  • VRAX $0.60
  • 52 Week High
  • OMH $1.32
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • OMH 49.80
  • VRAX 48.34
  • Support Level
  • OMH $0.33
  • VRAX $1.58
  • Resistance Level
  • OMH $0.37
  • VRAX $2.10
  • Average True Range (ATR)
  • OMH 0.02
  • VRAX 0.25
  • MACD
  • OMH 0.00
  • VRAX 0.01
  • Stochastic Oscillator
  • OMH 70.48
  • VRAX 44.59

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: